Peroxisome Proliferator-Activated Receptors and Acute Lung Injury

• Main Authors: Rosanna Di Paola, Salvatore Cuzzocrea
• Format: Article
• Language: English
• Published: Hindawi Limited 2007-01-01
• Series: PPAR Research
• Online Access: http://dx.doi.org/10.1155/2007/63745

Peroxisome proliferator-activated receptors are ligand-activated transcription factors belonging to the nuclear hormone receptor superfamily. PPARs regulate several metabolic pathways by binding to sequence-specific PPAR response elements in the promoter region of target genes, including lipid biosynthesis and glucose metabolism. Recently, PPARs and their respective ligands have been implicated as regulators of cellular inflammatory and immune responses. These molecules are thought to exert anti-inflammatory effects by negatively regulating the expression of proinflammatory genes. Several studies have demonstrated that PPAR ligands possess anti-inflammatory properties and that these properties may prove helpful in the treatment of inflammatory diseases of the lung. This review will outline the anti-inflammatory effects of PPARs and PPAR ligands and discuss their potential therapeutic effects in animal models of inflammatory lung disease.